Chengzhi Co., Ltd. engages in the clean energy, functional materials, medical healthcare, and life science and technology related businesses in China. The company produces and sells gas products, including carbon monoxide and purified synthesis gas, and industrial chemical products, such as ethylene, propylene, butanol, octanol, isobutyraldehyde, amino acid series products, and other pharmaceutical intermediates, as well as non-display materials, such as TFT- LCD liquid crystal materials, TV, MNT, NB, MB, TPC, vehicle, industrial control, PDLC, OLED materials, mixed liquid crystal materials, and glass products for display. It also produces and sells life science and technology products, such as D-ribose, arbutin, Lipox, D-ribose granule, and other biopharmaceutical and pharmaceutical intermediates, as well as cannabinoids, including CBDV and CBC. In addition, the company operates hospitals; and provides general surgery and oral and maxillofacial surgery treatment, and other medical services. Further, it engages in the TFT glass thinning and ITO glass coatings; daily-use chemical products; and trade of chemical raw materials; self-owned housing leasing, real estate brokerage, property management, computer network integration installation, and technical services; and sales of building materials, chemical products, clothing, shoes and hats, fuel oils, ceramic products, and computer software. Additionally, the company offers communication equipment, computers and accessories, electronic products, photographic equipment, household appliances, office supplies, and furniture lighting; mechanical equipment technology development and technical consulting; coal management; and import and export of goods and technologies. The company was founded in 1998 and is headquartered in Nanchang, China.